Publication Name	World Journal of Clinical Oncology
Manuscript ID	41743
Country	Spain

Received	2018-08-24 01:26
Peer-Review Started	2018-08-24 08:59
To Make the First Decision	2018-10-17 01:41
Return for Revision	2018-10-18 00:19
Revised	2018-10-30 19:14
Second Decision	2019-01-08 11:22
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2019-01-10 03:49
Articles in Press	2019-01-10 03:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2019-02-21 09:38
Publish the Manuscript Online	2019-02-22 04:33

ISSN	2218-4333 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Oligometastases in prostate cancer: Ablative treatment
Manuscript Source	Invited Manuscript
All Author List	Amalia Palacios-Eito, Amelia Béjar-Luque, Milagrosa Rodríguez-Liñán and Sonia García-Cabezas
ORCID	Author(s) ORCID Number Amalia Palacios-Eito http://orcid.org/0000-0002-7575-227X Amelia Béjar-Luque http://orcid.org/0000-0002-4133-3595 Milagrosa Rodríguez-Liñán http://orcid.org/0000-0003-1687-6464 Sonia García-Cabezas http://orcid.org/0000-0002-9373-9845
Funding Agency and Grant Number
Corresponding Author	Sonia García-Cabezas, MD, PhD, Associate Professor, Attending Doctor, Department of Radiation Oncology, Reina Sofia University Hospital, Avda. Menéndez Pidal, s/n, Cordoba 14004, Spain. songar1@gmail.com
Key Words	Oligometastases; Metastasis-directed therapy; Stereotactic body radiation therapy; Stereotactic ablative radiotherapy; Prostate cancer
Core Tip	The hypothesis that oligometastatic disease may be cured with local eradication therapies has led to the growing use in prostate cancer (PCa) of treatments targeted to metastasis, including stereotactic body radiation therapy (SBRT). Such therapy intends to complement, replace or delay the introduction of systemic therapy. The present review aims to compile the evidence from the main ongoing studies and results on SBRT in relation to oligometastatic PCa, and examines aspects where gaps in knowledge persist, e.g., optimum schemes, response assessment, and identification and diagnosis of oligometastatic patients.
Publish Date	2019-02-22 04:33
Citation	Palacios-Eito A, Béjar-Luque A, Rodríguez-Liñán M, García-Cabezas S. Oligometastases in prostate cancer: Ablative treatment. World J Clin Oncol 2019; 10(2): 38-51
URL	https://www.wjgnet.com/2218-4333/full/v10/i2/38.htm
DOI	https://dx.doi.org/10.5306/wjco.v10.i2.38

Full Article (PDF)	WJCO-10-38.pdf
Full Article (Word)	WJCO-10-38.docx
Manuscript File	41743-Review.docx
Answering Reviewers	41743-Answering reviewers.pdf
Audio Core Tip	41743-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	41743-Conflict-of-interest statement.pdf
Copyright License Agreement	41743-Copyright license agreement.pdf
Peer-review Report	41743-Peer-review(s).pdf
Scientific Misconduct Check	41743-Scientific misconduct check.pdf
Scientific Editor Work List	41743-Scientific editor work list.pdf